GNTA
Genenta Science SpA
NASDAQ · Healthcare · Biotechnology · IT
$0.66
−2.40%Next report
Analyst consensus
- Next report date
- Mar 3, 2027
- EPS estimate
- -$0.26
- Revenue estimate
- —
Latest reported
- Last report date
- Oct 10, 2025
- EPS actual
- -$0.24
- EPS estimate
- -$0.45
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +46.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 10, 2025 | -$0.45 | -$0.24 | Beat 46.37% | — |
| Jun 30, 2024 | — | -$0.24 | — | — |
| Oct 7, 2022 | — | -$0.12 | — | — |
| May 4, 2022 | — | -$0.11 | — | — |
| Dec 15, 2021 | — | -$0.33 | — | — |
| Dec 31, 2020 | — | -$0.26 | — | — |
| Dec 31, 2019 | — | -$0.14 | — | — |
| Jun 30, 2019 | — | -$0.14 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027